ARBEL , Tal

Disability progression in multiple sclerosis remains resistant to treatment. The absence of a suitable biomarker to allow for phase 2 clinical trials presents a high barrier for drug development. We propose to enable short proof-of-concept trials by increasing statistical power using a deep-learning predictive enrichment strategy. Specifically,...

This book constitutes the refereed joint proceedings of the First International Workshop on Graphs in Biomedical Image Analysis, GRAIL 2017, the 6th International Workshop on Mathematical Foundations of Computational Anatomy, MFCA 2017, and the Third International Workshop on Imaging Genetics, MICGen 2017, held in conjunction with the 20th...